| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/03/2002 | EP0833661B1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/03/2002 | EP0682527B1 Carbohydrate-based diagnostic reagent for trichinosis |
| 04/03/2002 | EP0666868B1 Use of anti-VEGF antibodies for the treatment of cancer |
| 04/03/2002 | EP0621786B1 Induced tolerance to xenografts |
| 04/03/2002 | CN1343257A Recombined procine adenovirus based viral vaccines and vectors |
| 04/03/2002 | CN1343127A Potentiation of anti-CD38-immunotoxin cytotoxicity |
| 04/03/2002 | CN1343125A Immunostimulant bacterial membrane tractions in cancer treatment |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1342771A Expression purification of tubercle mycobacterium Ag85B antigen and its application in vaccine |
| 04/03/2002 | CN1342753A Hepatitis C virus and its external cell culture method |
| 04/03/2002 | CN1342495A Mucosal immunovaccine |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365569 To protect animals from diseases caused by parasitic helminths |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365401 Nucleotide sequences in a vector; for development of vaccines and viricides |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365387 fabG |
| 04/02/2002 | US6365348 Obtaining biological sample, generating cdna, contacting with oligonucleotide primers of defined nucleotide sequence in polymerase chain reaction, detecting amount of cdna sequence that amplifies; using predetermined cut-off value |
| 04/02/2002 | US6365200 Topical skin sensitizer comprising water soluble gel vehicle and active ingredients consisting of benzalkonium chloride, vitamin e, and aloe; aphrodisiac |
| 04/02/2002 | US6365165 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 04/02/2002 | US6365163 Immunological tolerance-inducing agent |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | US6365151 Transfection; genetic engineering |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/28/2002 | WO2002024876A2 Live influenza vaccine and method of manufacture |
| 03/28/2002 | WO2002024746A1 Transfer factor from birds eggs |
| 03/28/2002 | WO2002024734A2 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024729A2 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | WO2002024224A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024220A2 Vaccine comprising heat stress proteins from herbaceous plants |
| 03/28/2002 | WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections |
| 03/28/2002 | WO2002024211A1 Immunomodulatory preparation |
| 03/28/2002 | WO2002024149A2 Immunogen comprising ligand bound hiv envelpe protein |
| 03/28/2002 | WO2002024147A2 Avian pneumovirus vaccine |
| 03/28/2002 | WO2002024145A2 Antiviral substances from plant cuticular and epicuticular material |
| 03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
| 03/28/2002 | WO2002000851A3 Helicobacter dd-heptosyltransferase |
| 03/28/2002 | WO2002000266A3 A method of treating and preventing infectious diseases |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001089454A3 Proteus mirabilis-based vaccine |
| 03/28/2002 | WO2001089361A3 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 03/28/2002 | WO2001087939A3 Genes required for natural competence, proteins, and their use |
| 03/28/2002 | WO2001085904A3 A novel polypeptide--- a human protein 9 containing the fragment of prion characteristic sequence and polynucleotide encoding it |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001085202A3 Electroporation for introduction of molecules into cells |
| 03/28/2002 | WO2001080880A3 Apoptotic agents |
| 03/28/2002 | WO2001078774A3 Recombinant intracellular pathogen vaccines and methods for use |
| 03/28/2002 | WO2001077299A3 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001073026A3 43238, a novel g protein-coupled receptor and uses therefor |
| 03/28/2002 | WO2001070774B1 Human t cell response to mhc-binding motif clusters |
| 03/28/2002 | WO2001066751A3 G protein-coupled receptors |
| 03/28/2002 | WO2001066124A3 Composition for the treatment of heart failure |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001055330A3 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 03/28/2002 | WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 03/28/2002 | WO2000047722A3 Chimeric virus-like particles or chimeric capsomers from bvp (bovine papilloma virus) |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038112 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020037920 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037879 Monoclonal antibodies; veterinary medicine |
| 03/28/2002 | US20020037862 Muscle relaxants; sexual disorders |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037848 Alzheimer's disease; Parkinson's disease |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037341 Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/28/2002 | US20020037295 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
| 03/28/2002 | US20020037294 To protect animals from diseases caused by parasitic helminths, such heartworm disease |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |